1 / 9

Global Sales of Dengue Vaccines to Remain Largely Concentrated in Asia-Pacific, 2027

Burdening occurrence of dengue fever across the Asia-Pacific region has prompted the demand for effective vaccines and medications to supress this viral malaise. While several pharmaceutical companies are striving to develop a cure for dengue, the fever’s incidence rate in Asia-Pacific is rising at an alarming rate. A recent report published by Future Market Insights predicts that in 2017, an estimated 70.3% of global dengue vaccines market will be dominated by Asia-Pacific. Through 2027, the region will continue to be the largest market for dengue vaccines, procuring a majority revenue share and projecting revenue growth at a 17.4% CAGR.<br><br>Future Market Insights also observes Latin America as the second-largest market for dengue vaccines, and is expected to rake in US$ 288.7 Mn towards the end of 2027. The report, titled “Dengue Vaccines Market: Global Industry Analysis and Opportunity Assessment, 2017-2027,” expects that more and more pharmaceutical giants from across the globe will be partaking in the market’s growth in the years to come. Currently, the market is witnessing active participation of French drugmaker, Sanofi S.A., while vaccines being formulated by companies such as Biological E. Limited, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Merck & Co. Inc., Vabiotech, Butantan Institute, and Panacea Biotech Ltd. are under multiple phases of development.

Monica2016
Download Presentation

Global Sales of Dengue Vaccines to Remain Largely Concentrated in Asia-Pacific, 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Dengue Vaccines Market: Global Industry Analysis and Opportunity Assessment, 2017-2027 May2017 Report Id : REP-GB-1763 Status : March-2017 Category : Healthcare, Pharmaceuticals & Medical Devices ©2015 Future Market Insights, All Rights Reserved

  2. About Future Market Insights Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights,aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology,Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solutionfor our client. Research Capabilities Sector Coverage             Customized Research Syndicated Research Investment Research Social Media Research Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas Customized Research Subscription Information Syndicated Research For detailed subscription information please contact Hari. T (Sr. Manager - Global Business Development) Investment Research T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com Social Media Research ©2015 Future Market Insights, All Rights Reserved 2

  3. Research Methodology (1/2) Systematic Research Approach 1 In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc. Research & Intelligence Data Collection Data Filter & Analysis Actionable Insights Business Solution Market profiling 2 PMR formulates a detailed discussion guide to conduct expert and industry interviews     Identifying key opinion leaders Questionnaire design In-depth interviews Coverage across value chain Formulating discussion guide 3 A PMR develops a list of industry players (manufacturers), distributors, retailers and industry experts Primary Research       Key industry experts Channel study Developments Market dynamics Products Conclusions Developing list of respondents B 4 PMR conducts interviews with industry experts, industry players, distributors and retailers SOLUTION Desk Research Data collection      Market participants Key strengths Product portfolio Mapping as per value chain Key focus segments C Company Analysis Data is validated by triangulation method, wherein secondary, primary and PMR analysis contribute to the final data 5 Data validation 6 Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry Data analysis Primary Research# Secondary Research # Paid Publications#           Linkedin Zoominfo Salesforce Avention Company websites Company annual reports White papers Financial reports Factiva GBI Genios Meltwater 7 PMR delivers industry insights and information in the required format (PDF) Insights   # includes sources of databases ©2015 Future Market Insights, All Rights Reserved 3

  4. Dengue Vaccine Market Burdening occurrence of dengue fever across the Asia-Pacific region has prompted the demand for effective vaccines and medications to supress this viral malaise. While several pharmaceutical companies are striving to develop a cure for dengue, the fever’s incidence rate in Asia-Pacific is rising at an alarming rate. A recent report published by Future Market Insights predicts that in 2017, an estimated 70.3% of global dengue vaccines market will be dominated by Asia-Pacific. Through 2027, the region will continue to be the largest market for dengue vaccines, procuring a majority revenue share and projecting revenue growth at a 17.4% CAGR. Future Market Insights also observes Latin America as the second-largest market for dengue vaccines, and is expected to rake in US$ 288.7 Mn towards the end of 2027. The report, titled “Dengue Vaccines Market: Global Industry Analysis and Opportunity Assessment, 2017-2027,” expects that more and more pharmaceutical giants from across the globe will be partaking in the market’s growth in the years to come. Currently, the market is witnessing active participation of French drugmaker, Sanofi S.A., while vaccines being formulated by companies such as Biological E. Limited, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Merck & Co. Inc., Vabiotech, Butantan Institute, and Panacea Biotech Ltd. are under multiple phases of development. Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1763 The report further reveals that government institutes will remain the largest end-users of dengue vaccines in the world. Through 2027, a little less than US$ 650 Mn worth of revenues is expected to arise from sales of dengue vaccines across government institutes. Meanwhile, hospitals will also dominate the market by registering a 17.3% revenue CAGR. The market, at present, will witness sales of the sole of vaccine, ©2015 Future Market Insights, All Rights Reserved 4

  5. Dengue Vaccine Market Dengvaxia, developed by Sanofi. Furthermore, factors shaping up the dynamics of global dengue vaccines market, also compiled in the report, are:  Apart from the burdening outbreak of dengue in several countries, the economic turmoil in Latin America is projected to impact the global market’s growth at a macroeconomic level  Live attenuated vaccines are being developed & produced economically, thereby comforting vaccine makers as well as patients  However, lack of skilled professionals and unavailability of optimum diagnostic systems has given rise to cases where dengue fever is being treated as an undistinguished febrile disease  The global market for dengue vaccines holds an opportunistic breakthrough when drugmakers will be able to successfully develop effective vaccines for all age group Click here to Order a free sample ©2015 Future Market Insights, All Rights Reserved 5

  6. Table of Content 1. Executive Summary 2. Market Introduction 2.1. Market Taxonomy 3. Global Dengue Vaccine Market Analysis Scenario 3.1. Market Size (US$ Mn) and Forecast 3.1.1. Market Size and Y-o-Y Growth 3.1.2. Absolute $ Opportunity 3.2. Market Overview 4. Market Dynamics and USPs 4.1. Macro-economic Factors 4.2. Drivers 4.2.1. Supply Side 4.2.2. Demand Side 4.3. Restraints 4.4. Opportunity 4.5. Trends 4.6. Dengue Vaccine Research Pipeline Analysis 4.7. Global Dengue Vaccine Market: Funding Scenario 4.8. Global Dengue Vaccine Market: Dengue Epidemiology Analysis 4.9. Global Dengue Vaccine Market: Dengvaxia SWOT 4.10. Global Dengue Vaccine Market: Dengvaxia Promotional Activities ©2015 Future Market Insights, All Rights Reserved 6

  7. Table of Content 5. Global Dengue Vaccine Opportunity Analysis and Forecasts, By End User 5.1. Introduction 5.2. Basis Point Share (BPS) Analysis By End User 5.3. Y-o-Y Growth Projections By End User 5.4. Market Value Forecast By End User, 2017–2027 5.4.1. Hospitals 5.4.2. Government Institutes 5.4.3. NGOs 5.5. Prominent Trends 5.6. Market Attractiveness By End User 6. Global Dengue Vaccine Opportunity Analysis and Forecasts, By Region 6.1. Basis Point Share (BPS) Analysis By Region 6.2. Y-o-Y Growth Projections By Region 6.3. Market Value Forecast By Region 6.3.1. Latin America 6.3.2. Asia Pacific 6.3.3. Middle East and Africa (MEA) 6.3.4. Rest of the World (RoW) 6.4. Market Attractiveness By Region ©2015 Future Market Insights, All Rights Reserved 7

  8. Table of Content 7. Latin America Dengue Vaccine Opportunity Analysis and Forecast 7.1. Introduction 7.1.1. Basis Point Share (BPS) Analysis By Country 7.1.2. Y-o-Y Growth Projections By Country 7.2. Market Value Forecast By, 2016–2026 7.3. Market Value Forecast By End User, 2016–2026 7.3.1. Hospitals 7.3.2. Government Institutes 7.3.3. NGOs 7.4. Market Value Forecast By Country, 2016–2026 7.4.1. Brazil 7.4.2. Mexico 7.4.3. Venezuela 7.4.4. Rest of Latin America 7.5. Market Attractiveness Analysis 7.5.1. By End User 7.5.2. By Country Click here to Order a free sample ©2015 Future Market Insights, All Rights Reserved 8

  9. To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: sales@futuremarketinsights.com For media queries, contact the press office at press@futuremarketinsights.com For other queries contact: Hari. T (Sr. Manager - Global Business Development) Future Market Insights: 3rd Floor, 207 Regent Street, London W1B 3HH T: +44 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com Future Market Insights Global & Consulting Private Limited (FMI) Thank You ©2015 Future Market Insights, All Rights Reserved 9

More Related